Cargando…
Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882990/ https://www.ncbi.nlm.nih.gov/pubmed/36702336 http://dx.doi.org/10.18632/oncotarget.28345 |
| _version_ | 1784879413803876352 |
|---|---|
| author | Vanderhoeven, Fiorella Redondo, Analía Lourdes Martinez, Ana Laura Vargas-Roig, Laura María Sanchez, Angel Matias Flamini, Marina Inés |
| author_facet | Vanderhoeven, Fiorella Redondo, Analía Lourdes Martinez, Ana Laura Vargas-Roig, Laura María Sanchez, Angel Matias Flamini, Marina Inés |
| author_sort | Vanderhoeven, Fiorella |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9882990 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98829902023-01-30 Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells Vanderhoeven, Fiorella Redondo, Analía Lourdes Martinez, Ana Laura Vargas-Roig, Laura María Sanchez, Angel Matias Flamini, Marina Inés Oncotarget Correction Impact Journals LLC 2023-01-26 /pmc/articles/PMC9882990/ /pubmed/36702336 http://dx.doi.org/10.18632/oncotarget.28345 Text en Copyright: © 2023 Vanderhoeven et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Vanderhoeven, Fiorella Redondo, Analía Lourdes Martinez, Ana Laura Vargas-Roig, Laura María Sanchez, Angel Matias Flamini, Marina Inés Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title | Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title_full | Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title_fullStr | Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title_full_unstemmed | Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title_short | Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
| title_sort | correction: synergistic antitumor activity by combining trastuzumab with retinoic acid in her2 positive human breast cancer cells |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882990/ https://www.ncbi.nlm.nih.gov/pubmed/36702336 http://dx.doi.org/10.18632/oncotarget.28345 |
| work_keys_str_mv | AT vanderhoevenfiorella correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells AT redondoanalialourdes correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells AT martinezanalaura correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells AT vargasroiglauramaria correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells AT sanchezangelmatias correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells AT flaminimarinaines correctionsynergisticantitumoractivitybycombiningtrastuzumabwithretinoicacidinher2positivehumanbreastcancercells |